nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—Bopindolol—Carteolol—glaucoma	0.604	1	CrCrCtD
Mebendazole—CYP1A1—Clonidine—glaucoma	0.0692	0.257	CbGbCtD
Mebendazole—CYP3A4—Pilocarpine—glaucoma	0.0332	0.123	CbGbCtD
Mebendazole—ABCB1—Timolol—glaucoma	0.0318	0.118	CbGbCtD
Mebendazole—ABCB1—Clonidine—glaucoma	0.027	0.101	CbGbCtD
Mebendazole—CYP3A4—Brinzolamide—glaucoma	0.026	0.0968	CbGbCtD
Mebendazole—CYP3A4—Dorzolamide—glaucoma	0.0251	0.0935	CbGbCtD
Mebendazole—CYP3A4—Methazolamide—glaucoma	0.0224	0.0833	CbGbCtD
Mebendazole—CYP3A4—Acetazolamide—glaucoma	0.0179	0.0666	CbGbCtD
Mebendazole—CYP3A4—Clonidine—glaucoma	0.0162	0.0602	CbGbCtD
Mebendazole—TUBA1A—optic choroid—glaucoma	0.00733	0.493	CbGeAlD
Mebendazole—Convulsion—Physostigmine—glaucoma	0.00285	0.056	CcSEcCtD
Mebendazole—Menorrhagia—Pilocarpine—glaucoma	0.00244	0.048	CcSEcCtD
Mebendazole—TUBA1A—Loss of Nlp from mitotic centrosomes—FGFR1OP—glaucoma	0.00242	0.0406	CbGpPWpGaD
Mebendazole—TUBA1A—Centrosome maturation—FGFR1OP—glaucoma	0.00214	0.036	CbGpPWpGaD
Mebendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00197	0.033	CbGpPWpGaD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00193	0.0324	CbGpPWpGaD
Mebendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00185	0.031	CbGpPWpGaD
Mebendazole—Agranulocytosis—Diclofenamide—glaucoma	0.00171	0.0336	CcSEcCtD
Mebendazole—Hypersensitivity—Dipivefrin—glaucoma	0.00168	0.033	CcSEcCtD
Mebendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.0016	0.0269	CbGpPWpGaD
Mebendazole—Agranulocytosis—Methazolamide—glaucoma	0.00157	0.0309	CcSEcCtD
Mebendazole—TUBA1A—G2/M Transition—FGFR1OP—glaucoma	0.00148	0.0248	CbGpPWpGaD
Mebendazole—TUBA1A—eye—glaucoma	0.00148	0.0992	CbGeAlD
Mebendazole—TUBA1A—retina—glaucoma	0.00146	0.0983	CbGeAlD
Mebendazole—TUBB4B—Loss of Nlp from mitotic centrosomes—FGFR1OP—glaucoma	0.00146	0.0245	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.00146	0.0245	CbGpPWpGaD
Mebendazole—TUBA1A—connective tissue—glaucoma	0.00142	0.0955	CbGeAlD
Mebendazole—TUBA1A—G2/M Transition—RAB8A—glaucoma	0.00139	0.0233	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00137	0.023	CbGpPWpGaD
Mebendazole—TUBB4B—Centrosome maturation—FGFR1OP—glaucoma	0.00129	0.0217	CbGpPWpGaD
Mebendazole—TUBA1A—G2/M Transition—OPTN—glaucoma	0.0012	0.0202	CbGpPWpGaD
Mebendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00119	0.0199	CbGpPWpGaD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—OPTN—glaucoma	0.00119	0.0199	CbGpPWpGaD
Mebendazole—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00118	0.0198	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00116	0.0196	CbGpPWpGaD
Mebendazole—Convulsion—Methazolamide—glaucoma	0.00114	0.0224	CcSEcCtD
Mebendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00112	0.0189	CbGpPWpGaD
Mebendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00112	0.0187	CbGpPWpGaD
Mebendazole—Agranulocytosis—Acetazolamide—glaucoma	0.00109	0.0214	CcSEcCtD
Mebendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00102	0.0172	CbGpPWpGaD
Mebendazole—CYP1A1—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00102	0.0172	CbGpPWpGaD
Mebendazole—Agranulocytosis—Dorzolamide—glaucoma	0.000998	0.0196	CcSEcCtD
Mebendazole—TUBB4B—eye—glaucoma	0.000984	0.0661	CbGeAlD
Mebendazole—TUBB4B—retina—glaucoma	0.000975	0.0655	CbGeAlD
Mebendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.000968	0.0163	CbGpPWpGaD
Mebendazole—TUBB4B—connective tissue—glaucoma	0.000948	0.0637	CbGeAlD
Mebendazole—Hypersensitivity—Metipranolol—glaucoma	0.000945	0.0186	CcSEcCtD
Mebendazole—Hepatitis—Pilocarpine—glaucoma	0.000907	0.0178	CcSEcCtD
Mebendazole—Abdominal pain—Carbachol—glaucoma	0.000901	0.0177	CcSEcCtD
Mebendazole—Urticaria—Levobunolol—glaucoma	0.000892	0.0175	CcSEcCtD
Mebendazole—TUBB4B—G2/M Transition—FGFR1OP—glaucoma	0.000892	0.015	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.000879	0.0148	CbGpPWpGaD
Mebendazole—Hypersensitivity—Carteolol—glaucoma	0.000875	0.0172	CcSEcCtD
Mebendazole—Urticaria—Methazolamide—glaucoma	0.000854	0.0168	CcSEcCtD
Mebendazole—TUBB4B—G2/M Transition—RAB8A—glaucoma	0.000838	0.0141	CbGpPWpGaD
Mebendazole—Hypersensitivity—Levobunolol—glaucoma	0.000827	0.0163	CcSEcCtD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.000827	0.0139	CbGpPWpGaD
Mebendazole—Rash—Metipranolol—glaucoma	0.000808	0.0159	CcSEcCtD
Mebendazole—Dermatitis—Metipranolol—glaucoma	0.000808	0.0159	CcSEcCtD
Mebendazole—Convulsion—Acetazolamide—glaucoma	0.00079	0.0155	CcSEcCtD
Mebendazole—Angioedema—Dorzolamide—glaucoma	0.000764	0.015	CcSEcCtD
Mebendazole—CYP1A1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000762	0.0128	CbGpPWpGaD
Mebendazole—Ketorolac—PTGS2—glaucoma	0.000753	0.344	CrCbGaD
Mebendazole—Rash—Diclofenamide—glaucoma	0.000736	0.0145	CcSEcCtD
Mebendazole—TUBB4B—G2/M Transition—OPTN—glaucoma	0.000727	0.0122	CbGpPWpGaD
Mebendazole—Hepatitis—Clonidine—glaucoma	0.000725	0.0142	CcSEcCtD
Mebendazole—Rash—Carbachol—glaucoma	0.000719	0.0141	CcSEcCtD
Mebendazole—Dermatitis—Carbachol—glaucoma	0.000718	0.0141	CcSEcCtD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—OPTN—glaucoma	0.000717	0.012	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—NTRK1—glaucoma	0.000716	0.012	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Apraclonidine—glaucoma	0.00068	0.0134	CcSEcCtD
Mebendazole—Rash—Methazolamide—glaucoma	0.000678	0.0133	CcSEcCtD
Mebendazole—Dermatitis—Methazolamide—glaucoma	0.000677	0.0133	CcSEcCtD
Mebendazole—Abdominal pain—Apraclonidine—glaucoma	0.000658	0.0129	CcSEcCtD
Mebendazole—Rash—Latanoprost—glaucoma	0.000656	0.0129	CcSEcCtD
Mebendazole—Agranulocytosis—Betaxolol—glaucoma	0.000656	0.0129	CcSEcCtD
Mebendazole—Dermatitis—Latanoprost—glaucoma	0.000656	0.0129	CcSEcCtD
Mebendazole—Tiaprofenic acid—PTGS2—glaucoma	0.000614	0.281	CrCbGaD
Mebendazole—Hypersensitivity—Apraclonidine—glaucoma	0.000613	0.012	CcSEcCtD
Mebendazole—Urticaria—Acetazolamide—glaucoma	0.000591	0.0116	CcSEcCtD
Mebendazole—CYP1A1—Estrogen metabolism—CYP1B1—glaucoma	0.000587	0.00986	CbGpPWpGaD
Mebendazole—Nepafenac—PTGS2—glaucoma	0.000584	0.267	CrCbGaD
Mebendazole—Angioedema—Clonidine—glaucoma	0.000576	0.0113	CcSEcCtD
Mebendazole—TUBA1A—p73 transcription factor network—FAS—glaucoma	0.000561	0.00942	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Dorzolamide—glaucoma	0.000558	0.011	CcSEcCtD
Mebendazole—Gastrointestinal pain—Travoprost—glaucoma	0.000555	0.0109	CcSEcCtD
Mebendazole—TUBA1A—Metabolism of proteins—DHPS—glaucoma	0.000543	0.00912	CbGpPWpGaD
Mebendazole—Urticaria—Dorzolamide—glaucoma	0.000542	0.0107	CcSEcCtD
Mebendazole—Abdominal pain—Dorzolamide—glaucoma	0.000539	0.0106	CcSEcCtD
Mebendazole—Abdominal pain—Travoprost—glaucoma	0.000537	0.0106	CcSEcCtD
Mebendazole—Agranulocytosis—Timolol—glaucoma	0.000536	0.0105	CcSEcCtD
Mebendazole—Urticaria—Brinzolamide—glaucoma	0.000533	0.0105	CcSEcCtD
Mebendazole—Gastrointestinal pain—Pilocarpine—glaucoma	0.000527	0.0104	CcSEcCtD
Mebendazole—Hypersensitivity—Brimonidine—glaucoma	0.000526	0.0103	CcSEcCtD
Mebendazole—Dermatitis—Apraclonidine—glaucoma	0.000524	0.0103	CcSEcCtD
Mebendazole—CYP1A1—Tamoxifen metabolism—CYP1B1—glaucoma	0.000519	0.00872	CbGpPWpGaD
Mebendazole—Abdominal pain—Pilocarpine—glaucoma	0.00051	0.01	CcSEcCtD
Mebendazole—Rash—Bimatoprost—glaucoma	0.000509	0.01	CcSEcCtD
Mebendazole—Dermatitis—Bimatoprost—glaucoma	0.000508	0.00999	CcSEcCtD
Mebendazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000503	0.00845	CbGpPWpGaD
Mebendazole—Hypersensitivity—Dorzolamide—glaucoma	0.000503	0.00988	CcSEcCtD
Mebendazole—Hypersensitivity—Travoprost—glaucoma	0.0005	0.00984	CcSEcCtD
Mebendazole—Hypersensitivity—Brinzolamide—glaucoma	0.000494	0.00971	CcSEcCtD
Mebendazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000492	0.00826	CbGpPWpGaD
Mebendazole—Hypersensitivity—Pilocarpine—glaucoma	0.000475	0.00933	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00047	0.00789	CbGpPWpGaD
Mebendazole—CYP1A1—Estrogen metabolism—GSTM1—glaucoma	0.000469	0.00788	CbGpPWpGaD
Mebendazole—Rash—Brimonidine—glaucoma	0.00045	0.00885	CcSEcCtD
Mebendazole—Dermatitis—Brimonidine—glaucoma	0.00045	0.00884	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000442	0.00742	CbGpPWpGaD
Mebendazole—Rash—Dorzolamide—glaucoma	0.00043	0.00845	CcSEcCtD
Mebendazole—Dermatitis—Dorzolamide—glaucoma	0.00043	0.00845	CcSEcCtD
Mebendazole—Rash—Travoprost—glaucoma	0.000428	0.00842	CcSEcCtD
Mebendazole—Dermatitis—Travoprost—glaucoma	0.000428	0.00841	CcSEcCtD
Mebendazole—Rash—Brinzolamide—glaucoma	0.000423	0.00831	CcSEcCtD
Mebendazole—Dermatitis—Brinzolamide—glaucoma	0.000422	0.0083	CcSEcCtD
Mebendazole—Gastrointestinal pain—Clonidine—glaucoma	0.000421	0.00827	CcSEcCtD
Mebendazole—TUBA1A—Cell Cycle—FGFR1OP—glaucoma	0.00042	0.00705	CbGpPWpGaD
Mebendazole—Angioedema—Timolol—glaucoma	0.00041	0.00806	CcSEcCtD
Mebendazole—Urticaria—Clonidine—glaucoma	0.000409	0.00804	CcSEcCtD
Mebendazole—Abdominal pain—Clonidine—glaucoma	0.000407	0.008	CcSEcCtD
Mebendazole—Rash—Pilocarpine—glaucoma	0.000406	0.00799	CcSEcCtD
Mebendazole—Dermatitis—Pilocarpine—glaucoma	0.000406	0.00798	CcSEcCtD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—PEX19—glaucoma	0.000405	0.0068	CbGpPWpGaD
Mebendazole—CYP1A1—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000401	0.00673	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—RAB8A—glaucoma	0.000395	0.00663	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000383	0.00643	CbGpPWpGaD
Mebendazole—Hypersensitivity—Clonidine—glaucoma	0.000379	0.00745	CcSEcCtD
Mebendazole—Urticaria—Betaxolol—glaucoma	0.000356	0.007	CcSEcCtD
Mebendazole—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000348	0.00584	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—OPTN—glaucoma	0.000342	0.00575	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CTSA—glaucoma	0.000339	0.00569	CbGpPWpGaD
Mebendazole—Hypersensitivity—Betaxolol—glaucoma	0.00033	0.00649	CcSEcCtD
Mebendazole—TUBB4B—Metabolism of proteins—DHPS—glaucoma	0.000328	0.00551	CbGpPWpGaD
Mebendazole—Rash—Clonidine—glaucoma	0.000325	0.00638	CcSEcCtD
Mebendazole—Dermatitis—Clonidine—glaucoma	0.000324	0.00637	CcSEcCtD
Mebendazole—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000324	0.00544	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—ACE2—glaucoma	0.000312	0.00524	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00031	0.00521	CbGpPWpGaD
Mebendazole—Gastrointestinal pain—Timolol—glaucoma	0.000299	0.00588	CcSEcCtD
Mebendazole—Urticaria—Timolol—glaucoma	0.000291	0.00572	CcSEcCtD
Mebendazole—Abdominal pain—Timolol—glaucoma	0.000289	0.00569	CcSEcCtD
Mebendazole—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000289	0.00485	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000284	0.00476	CbGpPWpGaD
Mebendazole—ABCB1—retina—glaucoma	0.000284	0.019	CbGeAlD
Mebendazole—Rash—Betaxolol—glaucoma	0.000283	0.00555	CcSEcCtD
Mebendazole—Dermatitis—Betaxolol—glaucoma	0.000282	0.00555	CcSEcCtD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000282	0.00473	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000277	0.00465	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000277	0.00465	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000277	0.00465	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000274	0.00459	CbGpPWpGaD
Mebendazole—Hypersensitivity—Timolol—glaucoma	0.00027	0.0053	CcSEcCtD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000267	0.00448	CbGpPWpGaD
Mebendazole—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000264	0.00443	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000259	0.00435	CbGpPWpGaD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000255	0.00429	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—FGFR1OP—glaucoma	0.000254	0.00426	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RAB8A—glaucoma	0.000238	0.004	CbGpPWpGaD
Mebendazole—Ketoprofen—PTGS2—glaucoma	0.000237	0.108	CrCbGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—OPTN—glaucoma	0.000231	0.00388	CbGpPWpGaD
Mebendazole—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000231	0.00388	CbGpPWpGaD
Mebendazole—Rash—Timolol—glaucoma	0.000231	0.00454	CcSEcCtD
Mebendazole—Dermatitis—Timolol—glaucoma	0.000231	0.00453	CcSEcCtD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000224	0.00376	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000221	0.00371	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—OPTN—glaucoma	0.000207	0.00347	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CTSA—glaucoma	0.000205	0.00344	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—ACE2—glaucoma	0.000188	0.00316	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000183	0.00307	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000182	0.00305	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND2—glaucoma	0.000176	0.00295	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000174	0.00292	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—PAX6—glaucoma	0.000166	0.0028	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000158	0.00265	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND2—glaucoma	0.000157	0.00264	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2B—glaucoma	0.000141	0.00237	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	0.000138	0.00232	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000136	0.00229	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000135	0.00227	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000134	0.00225	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000134	0.00224	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000125	0.0021	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000123	0.00207	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTT1—glaucoma	0.000121	0.00203	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000118	0.00199	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000118	0.00199	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000117	0.00196	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000115	0.00194	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00011	0.00185	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000109	0.00183	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND2—glaucoma	0.000106	0.00178	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—FAS—glaucoma	0.000103	0.00173	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—C3—glaucoma	0.000101	0.0017	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—PAX6—glaucoma	0.0001	0.00169	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	9.84e-05	0.00165	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP1B1—glaucoma	9.65e-05	0.00162	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	9.52e-05	0.0016	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2B—glaucoma	9.52e-05	0.0016	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND2—glaucoma	9.49e-05	0.00159	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP1—glaucoma	9.47e-05	0.00159	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	9.3e-05	0.00156	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.01e-05	0.00151	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—glaucoma	9.01e-05	0.00151	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	8.98e-05	0.00151	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.94e-05	0.0015	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.69e-05	0.00146	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2B—glaucoma	8.51e-05	0.00143	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CA5A—glaucoma	8.49e-05	0.00143	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NARFL—glaucoma	8.49e-05	0.00143	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	8.43e-05	0.00142	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	8.43e-05	0.00142	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.31e-05	0.0014	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—glaucoma	8.06e-05	0.00135	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1B—glaucoma	7.98e-05	0.00134	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTM1—glaucoma	7.71e-05	0.0013	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	7.61e-05	0.00128	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP2—glaucoma	7.33e-05	0.00123	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1B—glaucoma	7.14e-05	0.0012	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA5A—glaucoma	6.78e-05	0.00114	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NARFL—glaucoma	6.78e-05	0.00114	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.48e-05	0.00109	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.97e-05	0.001	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.96e-05	0.001	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.94e-05	0.000997	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	5.89e-05	0.000989	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP1—glaucoma	5.72e-05	0.000961	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.55e-05	0.000932	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—glaucoma	5.44e-05	0.000914	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—glaucoma	5.1e-05	0.000856	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.08e-05	0.000853	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—glaucoma	4.87e-05	0.000817	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—glaucoma	4.82e-05	0.000809	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.75e-05	0.000797	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.68e-05	0.000786	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—glaucoma	4.48e-05	0.000753	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP2—glaucoma	4.43e-05	0.000743	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—glaucoma	4.37e-05	0.000734	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.34e-05	0.00073	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1B—glaucoma	4.31e-05	0.000724	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA5A—glaucoma	4.18e-05	0.000701	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NARFL—glaucoma	4.18e-05	0.000701	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CA1—glaucoma	4.15e-05	0.000696	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.06e-05	0.000682	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CTSA—glaucoma	4.01e-05	0.000674	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.8e-05	0.000638	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CA2—glaucoma	3.79e-05	0.000637	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.74e-05	0.000629	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.71e-05	0.000622	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.71e-05	0.000622	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA1—glaucoma	3.31e-05	0.000556	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CTSA—glaucoma	3.21e-05	0.000538	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.19e-05	0.000536	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA2—glaucoma	3.03e-05	0.000509	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.03e-05	0.000508	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—glaucoma	2.71e-05	0.000455	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TXN—glaucoma	2.67e-05	0.000449	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.52e-05	0.000423	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.44e-05	0.000409	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.41e-05	0.000406	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.16e-05	0.000362	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TXN—glaucoma	2.13e-05	0.000358	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTT1—glaucoma	2.07e-05	0.000348	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA1—glaucoma	2.04e-05	0.000343	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CTSA—glaucoma	1.98e-05	0.000332	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.9e-05	0.000319	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA2—glaucoma	1.87e-05	0.000313	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.67e-05	0.00028	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTT1—glaucoma	1.65e-05	0.000278	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP1B1—glaucoma	1.65e-05	0.000277	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCA1—glaucoma	1.65e-05	0.000277	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—glaucoma	1.32e-05	0.000222	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1B1—glaucoma	1.32e-05	0.000221	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ABCA1—glaucoma	1.32e-05	0.000221	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TXN—glaucoma	1.31e-05	0.000221	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—glaucoma	1.17e-05	0.000196	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOE—glaucoma	1.09e-05	0.000182	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CAV1—glaucoma	1.08e-05	0.000181	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—glaucoma	1.05e-05	0.000177	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTT1—glaucoma	1.02e-05	0.000171	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—glaucoma	9.31e-06	0.000156	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOE—glaucoma	8.67e-06	0.000146	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CAV1—glaucoma	8.59e-06	0.000144	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NOS3—glaucoma	8.13e-06	0.000137	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCA1—glaucoma	8.12e-06	0.000136	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1B1—glaucoma	8.12e-06	0.000136	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—glaucoma	7.44e-06	0.000125	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NOS3—glaucoma	6.49e-06	0.000109	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—glaucoma	6.49e-06	0.000109	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—glaucoma	5.94e-06	9.98e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—glaucoma	5.74e-06	9.64e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOE—glaucoma	5.34e-06	8.97e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CAV1—glaucoma	5.29e-06	8.89e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NOS3—glaucoma	4e-06	6.72e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—glaucoma	3.66e-06	6.15e-05	CbGpPWpGaD
